Clinical Trials Browser

Completed × INDUSTRY × Rabeprazole × Clear all

NCT06787131 2025-12-05

Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05407675 2025-10-03

A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors

Phase 1/2 Completed

68 enrolled 27 charts

Neoplasms

NCT05602597 2024-03-06

HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPI

Phase 1 Completed

Lymphoma, Recurrence

NCT05930119 2023-09-06

HMPL-453 Food Effect and PPI Study in Healthy Volunteer Study

Phase 1 Completed

Gastrointestinal

Cholangiocarcinoma

NCT05571787 2023-02-23

HMPL-523 Food Effect and Proton Pump Inhibitor Study

Phase 1 Completed

Lymphoma, Recurrence

NCT04944771 2022-05-09

Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Participants

Phase 1 Completed

Other hematologic neoplasm

Hematologic Neoplasms

NCT04564040 2020-12-29

A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole

Phase 1 Completed

COVID-19, Lymphoma, Mantle-Cell

NCT03117101 2017-04-17

Study of the AL3810 in the Treatment of Advanced Solid Tumor

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT01264822 2017-02-27

Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori

Gastrointestinal

Stomach Neoplasms